4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000129
Chief Financial Officer sold 2,542 shares at $49.03 ($124,634)
- Chief Financial Officer acquired 7,473 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,473 | 22,700 | D | ||
| 2024-09-26 | Sale : show line 2 in the form 10b5-1 | −2,542 | $49.03 | $124,634 | 20,158 | D |
| Open-market sales · 2,542 sh · avg $49.03 · $124,634 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-26 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −7,473 | 7,472 | D |
Loading xslF345X05/wk-form4_1727727323.xml…